Ospedale Mater Salutis Di Legnago

Legnago 16 trials 9 recruiting

16 Registered trials

9 Currently recruiting

Organisation

Ospedale Mater Salutis Di Legnago

Location

Legnago, Italy

Identifier

ORG-100041771

Address

Via Carlo Gianella 1, 37045, Italy

Departments

2405: UOC Cardiologia-Emodinamica
Cardiologia
Infectious Diseases
Medical Oncology
Oncologia Medica
Oncology
Ospedale Mater Salutis Oncologia Medica, Legnago AULSS 21
Pulmonary Medicine
Radiation oncology
U.O.C. Oncologia Medica
UOC Oncologia Medica

Clinical trials at this site (16)

Search interface

Study comparing single versus dual antiplatelet therapy in elderly patients or patients at risk of bleeding undergoing balloon surgery. Recruiting

2024-519706-13-00 Patients with Stable or Unstable coronary syndromes who 6 2026-01-26
A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K in… Recruiting

2022-501152-28-00 Breast Cancer 4 2022-12-21
Lp(a) lowering study of pelacarsen (TQJ230) with background inclisiran in participants with elevated Lp(a) and established ASCVD Recruiting

2024-516356-18-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-02-17
EORTC-2238-GUCG: Improving impact of anti-androgen treatments on patient's daily life and their cancer Recruiting

2023-506817-23-01 Metastatic hormone naïve prostate cancer (mHNPC) 5 2025-05-23
Efecto de la inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas oligometastásico (número limitado de metástasis) después… Recruiting

2023-508741-40-00 Non-small cell lung cancer 10 2025-01-14
MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The M… Recruiting

2024-516841-38-00 recurrent ovarian cancer wild type for germline and som 4 2025-01-09
MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, … Recruiting

2024-516839-27-00 BRCA wild-type advanced ovarian, fallopian tube and pri 4 2024-12-09
Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting

2023-505267-36-00 Glioblastoma 5 2024-03-15
An international, multicenter, randomised, superiority phase III, open label, 2-arm study to investigate distant metastasis free survival wi… Recruiting

2022-501453-36-00 Breast cancer 5 2024-02-23
A clinical trial of relacorilant (study drug) with nab-paclitaxel in patients with ovarian, fallopian tube or peritoneal cancer Ended

2024-514080-25-00 Advanced, Platinum-Resistant, High-Grade Epithelial Ova 5 2023-04-21
MITO 25.1: A randomized, molecular driven phase II trial of Carboplatin-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel-Bevacizumab-Rucapar… Ended

2024-516632-99-00 Advanced (stage III B-C-IV) ovarian, primary peritoneal 4 2021-03-17
A Phase II study of post-operative palbociclib as an alternative to chemotherapy in older patients with localized breast cancer at high risk… Ended

2023-505223-31-00 Localized ER+ breast cancer 4 2019-06-14
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted

2024-515152-20-00 Stage III and high-risk stage II resected colon cancer 4 2023-03-02
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
A Study of Pembrolizumab Combination Therapy for Advanced Non-Small Cell Lung Cancer Ended

2022-500990-16-00 Stage IV non-small cell lung cancer 4 2018-12-19